Impax Small Cap Institutional holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Impax Small Cap Fund Institutional Class PXSIX
- NAV / 1-Day Return 21.91 / +0.64 %
- Total Assets 891.1M
-
Adj. Expense Ratio
0.910%
- Expense Ratio 0.910%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment 250,000
- Status Open
- TTM Yield 0.00
- Turnover 36%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0
Morningstar’s Analysis PXSIX
Will PXSIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 31.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Victory Capital Holdings Inc Class A | 5.46 | 52M | Financial Services |
Crinetics Pharmaceuticals Inc | 3.82 | 36M | Healthcare |
JPMorgan US Treasury Plus MMkt IM | 3.74 | 36M | Cash and Equivalents |
Pinnacle Financial Partners Inc | 3.65 | 35M | Financial Services |
Acadian Asset Management Inc | 3.18 | 30M | Financial Services |
Eastern Bankshares Inc Ordinary Shares | 3.08 | 29M | Financial Services |
Ligand Pharmaceuticals Inc | 2.87 | 27M | Healthcare |
Neurocrine Biosciences Inc | 2.80 | 27M | Healthcare |
SI-BONE Inc | 2.66 | 25M | Healthcare |
Teradata Corp | 2.23 | 21M | Technology |